U.S. market Open. Closes in 5 hours 36 minutes

RNLX | Renalytix Plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-30
Revenue2.29M3.40M2.97M1.49MN/AN/A
Cost of Revenue2.13M2.70M2.05M804.00K74.00K30.99K
Gross Profit156.00K701.00K918.00K687.00K-74.00K-30.99K
Operating Expenses29.04M43.06M58.29M33.30M11.08M6.54M
Selling, General & Admin19.75M43.06M12.95M8.37M11.08M6.54M
Research & Development9.29M14.30M14.65M10.04M4.57M39.60M
Other Operating Expenses249.00K656.00K30.69M14.88MN/AN/A
Operating Income-29.61M-42.35M-57.37M-32.61M-11.08M-6.54M
Other Expenses / Income-3.84M-3.38M7.74M-3.18M468.00K19.00K
Before Tax Income-33.45M-46.22M-49.63M-35.79M-10.61M-6.52M
Income Tax Expenses4.00K2.00K25.00KN/AN/A-959.00K
Net Income-33.46M-45.61M-45.28M-34.73M-9.84M-5.56M
Interest ExpensesN/AN/A2.00K3.00K2.00K20.00K
Basic Shares Outstanding108.18M82.21M67.98M70.87M57.91M21.28M
Diluted Shares Outstanding108.18M82.21M73.84M71.48M59.08M21.28M
EBITDA-23.54M-35.50M-45.11M-39.41M-11.08M-5.37M
EBITDA Margin-1,028.48%-1,043.11%-1,518.89%-2,643.26%0.00%0.00%
EBIT-33.45M-45.60M-45.25M-34.72M-9.84M-6.50M
EBIT Margin-1,461.42%-1,340.14%-1,523.54%-2,328.77%0.00%0.00%
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙